ConductScience.org, home

Gene · 79813

NIH grants1,962

NIH grants whose papers are about the gene, through NIH's grant-paper links.

241 to 260 of 1,962

Download this page as JSON
GrantTitleEHMT1 papersNewest fiscal year
R35GM141888Tracking how molecular machines propagate epigenetic information in time and space12025
R35GM149229Chemical Approaches to Understanding Reversible Lysine Modifications12025
R35NS111602Dynamic DNA Modifications in Brain and Diseases12025
R37NS095733Pathological Mechanisms of Human Cerebellar Malformations12025
RM1HG009490Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease12025
T32AI007001Training in Sexually Transmitted Infections and HIV12025
T32AI007290Molecular and Cellular Immunobiology12025
T32AI007517Training in Investigative Infectious Diseases12025
T32AT007533Research Training in Natural Product Complementary and Integrative Health12025
T32CA009109Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies12025
T32CA009171Training Program in Basic Cancer Research12025
T32CA009523Contemporary Approaches to Cancer Cell Signaling and Communication12025
T32CA059366Cancer Biology Training Grant12025
T32CA070085Training Program in Signal Transduction and Cancer12025
T32CA094186Computational Genomic Epidemiology of Cancer (CoGEC) Training Program12025
T32CA148724Cancer Biology Training Program12025
T32DK007314Diabetes, Endocrine, and Metabolism12025
T32DK007418Diabetes, Endocrinology & Metabolism Training Grant12025
T32DK007665Metabolism and Nutrition Training Program12025
T32DK007740Clinical Epidemiology Training in Gastroenterology12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/79813/grants?page=13